share_log

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Green Ralph Elias

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Green Ralph Elias

Vivos Therapeutics | 4:持股變動聲明-董事 Green Ralph Elias
美股sec公告 ·  06/28 20:57
Moomoo AI 已提取核心訊息
In a recent transaction, Ralph Elias Green engaged in the sale of shares from Vivos Therapeutics, Inc. (VVOS). The action took place on June 20, 2024. However, the specific details regarding the number of shares transacted, the nature of the shares, the transaction price, and the post-transaction shareholding were not disclosed. This information is critical for investors to assess the impact of the transaction on their investment decisions.
In a recent transaction, Ralph Elias Green engaged in the sale of shares from Vivos Therapeutics, Inc. (VVOS). The action took place on June 20, 2024. However, the specific details regarding the number of shares transacted, the nature of the shares, the transaction price, and the post-transaction shareholding were not disclosed. This information is critical for investors to assess the impact of the transaction on their investment decisions.
在最近的一筆交易中,Ralph Elias Green參股金融公司Vivos Therapeutics, Inc. (VVOS)的股份進行了出售。這次交易發生在2024年6月20日。然而,關於交易股數、股份性質、交易價格以及交易後的持股情況的具體細節沒有披露。這些信息對於投資者評估交易對其投資決策的影響至關重要。
在最近的一筆交易中,Ralph Elias Green參股金融公司Vivos Therapeutics, Inc. (VVOS)的股份進行了出售。這次交易發生在2024年6月20日。然而,關於交易股數、股份性質、交易價格以及交易後的持股情況的具體細節沒有披露。這些信息對於投資者評估交易對其投資決策的影響至關重要。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息